Hemoglobin Levels in Patients with Human Immunodeficiency Virus Na�ve Therapy Containing Zidovudine in the First Three Months

Abstract

Prasetyaning Estu Pratiwi, Usman Hadi, Muhammad Vitanata Arfijanto

Background: Zidovudine, one of the combination antiretroviral used to treat HIV/AIDS, is the most common cause of anemia in HIV patients. Anemia related to zidovudine in HIV can worsen HIV infection. This study determined the hemoglobin level and effect of zidovudine therapy on HIV naïve patients in the first three months initiation therapy. Methods: Observational analytic study with longitudinal prospective approach was carried out all new HIV patients who received zidovudine therapy. Hemoglobin examination was done at the beginning of the examination and every month for the first three months of zidovudine therapy. Results: Thirteen (38.23%) subjects developed a decrease in hemoglobin levels. The highest incidence of decreased hemoglobin levels in month 2 was in 11 (84.6%) subjects. The mean hemoglobin levels before the initiation of zidovudine ARV and after 3rd month therapy were 12.75±1.57 and 11.94±2.23 g/dl, respectively. The mean decrease in hemoglobin levels of zidovudine therapy was 2.24±1.99 g/dl. There was an effect of three months of zidovudine therapy on decreasing hemoglobin levels in HIV naïve patients with a statistical significance (p = 0.006). Conclusion: There was an effect of zidovudine therapy on decreasing hemoglobin levels in the first three months of ARV therapy HIV naïve patients.

Most Viewed Articles
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli SRP. 2020; 11(1): 01-06 » doi: 10.5530/srp.2020.1.01
  • Psychometric properties of the World Health Organization Quality of life instrument, short form: Validity in the Vietnamese healthcare context Trung Quang Vo*, Bao Tran Thuy Tran, Ngan Thuy Nguyen, Tram ThiHuyen Nguyen, Thuy Phan Chung Tran SRP. 2020; 11(1): 14-22 » doi: 10.5530/srp.2019.1.3
  • A Review of Pharmacoeconomics: the key to “Healthcare for All” Hasamnis AA, Patil SS, Shaik Imam, Narendiran K SRP. 2019; 10(1): s40-s42 » doi: 10.5530/srp.2019.1s.21
  • Deuterium Depleted Water as an Adjuvant in Treatment of Cancer Anton Syroeshkin, Olga Levitskaya, Elena Uspenskaya, Tatiana Pleteneva, Daria Romaykina, Daria Ermakova SRP. 2019; 10(1): 112-117 » doi: 10.5530/srp.2019.1.19
Most Downloaded
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli SRP. 2020; 11(1): 01-06 » doi: 10.5530/srp.2020.1.01
  • Manilkara zapota (L.) Royen Fruit Peel: A Phytochemical and Pharmacological Review Karle Pravin P, Dhawale Shashikant C SRP. 2019; 10(1): 11-14 » doi: 0.5530/srp.2019.1.2
  • Pharmacognostic and Phytopharmacological Overview on Bombax ceiba Pankaj Haribhau Chaudhary, Mukund Ganeshrao Tawar SRP. 2019; 10(1): 20-25 » doi: 10.5530/srp.2019.1.4
  • A Review of Pharmacoeconomics: the key to “Healthcare for All” Hasamnis AA, Patil SS, Shaik Imam, Narendiran K SRP. 2019; 10(1): s40-s42 » doi: 10.5530/srp.2019.1s.21
  • A Prospective Review on Phyto-Pharmacological Aspects of Andrographis paniculata Govindraj Akilandeswari, Arumugam Vijaya Anand, Palanisamy Sampathkumar, Puthamohan Vinayaga Moorthi, Basavaraju Preethi SRP. 2019; 10(1): 15-19 » doi: 10.5530/srp.2019.1.3